Egetis Therapeutics’ Shares Offering

Vinge advised Egetis Therapeutics on the deal. Egetis Therapeutics AB (publ), listed on Nasdaq Stockholm, completed a directed share issuances whereby Egetis Therapeutics receives gross proceeds...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Irisity’s Rights Offering

Vinge advised Irisity on the offering. Irisity AB (publ) completed its rights issuance of units consisting of shares and warrants. The issue is guaranteed to 80...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Axcel’s Launch of Accru Partners

Vinge advised Axcel on the deal. Nordic private equity firm Axcel established Accru Partners, a new group of 22 independent firms in Sweden within accounting, tax,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Logpoint’s Acquisition of Muninn

Moalem Weitemeyer advised Muninn on the deal. Logpoint finalized the acquisition of Muninn. Founded in 2016, Muninn set out to revolutionise cybersecurity by developing cutting-edge AI/ML-driven...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Coromandel Chemicals Limited’s Acquisition of a Stake in Baobab Mining and Chemicals Corporation

Cyril Amarchand Mangaldas (CAM) advised Coromandel Chemicals Limited and Coromandel International Limited on the deal. Coromandel Chemicals Limited (CCL) and Coromandel International Limited (Coromandel) secured the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here